Michael R Bishop

Michael R Bishop

UNVERIFIED PROFILE

Are you Michael R Bishop?   Register this Author

Register author
Michael R Bishop

Michael R Bishop

Publications by authors named "Michael R Bishop"

Are you Michael R Bishop?   Register this Author

94Publications

1949Reads

30Profile Views

The case for CAR T-cell therapy in follicular lymphomas.

Authors:
Michael R Bishop

Blood 2019 Aug;134(7):577-578

University of Chicago Medical Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.2019001843DOI Listing
August 2019

When Monoclonal Gammopathy is of Renal Significance: A Case Study of Crystalglobulinemia From Chicago Multiple Myeloma Rounds.

Clin Lymphoma Myeloma Leuk 2019 Jun 8;19(6):e251-e258. Epub 2019 Mar 8.

Division of Hematology, Oncology and Stem Cell Transplant, Rush University Medical Center, Chicago, IL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2019.02.008DOI Listing
June 2019

Prevention and treatment of relapse after stem cell transplantation in lymphoid malignancies.

Bone Marrow Transplant 2019 01 24;54(1):17-25. Epub 2018 May 24.

Division of Hematology Oncology, Blood and Marrow Transplant Program, University of Pennsylvania and Perelman School of Medicine, Philadelphia, PA, 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-018-0214-5DOI Listing
January 2019

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

N Engl J Med 2019 01 1;380(1):45-56. Epub 2018 Dec 1.

From the Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia (S.J.S.); the Hematopoietic Cellular Therapy Program, University of Chicago Medicine, Chicago (M.R.B.); Peter MacCallum Cancer Centre, St. Vincent's Hospital and University of Melbourne, Melbourne, VIC (C.S.T.), and the Royal Prince Alfred Hospital and Department of Medicine, University of Sydney, Sydney (P.J.H.) - both in Australia; Winship Cancer Institute of Emory University, Bone Marrow and Stem Cell Transplant Center, Atlanta (E.K.W.); the Department of Hematology and Oncology, University Hospital of Cologne, Cologne (P.B.), and the Würzburg University Medical Center, Center for Allogeneic Stem Cell Transplantation, Würzburg (S.M.) - both in Germany; the Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Cancer Center, Kansas City (J.P.M.); the Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna (U.J.); James Cancer Hospital and Solove Research Institute, Ohio State University Comprehensive Cancer Center, Columbus (S.J.); the Department of Hematology and Blood and Marrow Transplant, University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco (C.A.); the Department of Lymphoma and Myeloma, Division of Cancer Medicine, University of Texas M.D. Anderson Cancer Center, Houston (J.R.W.); Maisonneuve-Rosemont Hospital, University of Montreal, Montreal (I.F.), and the Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, ON (S.R.F.) - both in Canada; the Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis (V.B.); Karolinska Institutet and University Hospital, Department of Laboratory Medicine/Department of Cell Therapy and Allogeneic Stem Cell Transplantation, Stockholm (S.M.); University of Michigan Comprehensive Cancer Center, Ann Arbor (J.M.M.); the Department of Oncology, Oslo University Hospital, Oslo (H.H.); Novartis Pharma, Basel, Switzerland (S.P., O.A.); Novartis Pharmaceuticals (L.B.P., J.C.) and Novartis Institutes for BioMedical Research (R.A.), East Hanover, NJ; the Department of Hematology, Hospices Civils de Lyon, Université de Lyon, Lyon, France (G.S.); and the Center for Hematologic Malignancies, Oregon Health and Science University Knight Cancer Institute, Portland (R.T.M.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1804980
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1804980DOI Listing
January 2019

Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'.

Nat Rev Clin Oncol 2018 04 13;15(4):218. Epub 2018 Feb 13.

Department of Pediatrics and The Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2018.19DOI Listing
April 2018

Emerging role of checkpoint blockade therapy in lymphoma.

Ther Adv Hematol 2017 Feb 22;8(2):81-90. Epub 2017 Jan 22.

Section of Hematology and Oncology, University of Chicago, 5841 S. Maryland Avenue, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620716673787DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298386PMC
February 2017

Mature T- and NK-cell non-Hodgkin lymphoma in children and young adolescents.

Br J Haematol 2016 05 15;173(4):573-81. Epub 2016 Mar 15.

Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, University of Pennsylvania, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14044DOI Listing
May 2016

Update on checkpoint blockade therapy for lymphoma.

J Immunother Cancer 2015 21;3:33. Epub 2015 Jul 21.

Department of Medicine, University of Chicago, 5841 S. Maryland Ave., MC2115, Chicago, IL 60637 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-015-0079-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509696PMC
July 2015

Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: introduction.

Biol Blood Marrow Transplant 2013 Nov 10;19(11):1534-6. Epub 2013 Sep 10.

Children's Center for Cancer and Blood Diseases, Division of Hematology, Oncology, and Blood and Marrow Transplantation, Children's Hospital Los Angeles, The Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California; Organizing Committee, National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.08.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880421PMC
November 2013

Treatments of disease relapse after allogeneic stem cell transplantation focusing on donor lymphocyte infusion.

Chin Med J (Engl) 2013 Nov;126(22):4380-8

Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA.

View Article

Download full-text PDF

Source
November 2013

Host lymphocyte depletion as a strategy to facilitate early full donor chimerism after reduced-intensity allogeneic stem cell transplantation.

Biol Blood Marrow Transplant 2013 Oct 13;19(10):1509-13. Epub 2013 Aug 13.

Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland; Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.08.001DOI Listing
October 2013

Rapid complete donor lymphoid chimerism and graft-versus-leukemia effect are important in early control of chronic lymphocytic leukemia.

Exp Hematol 2013 Sep 18;41(9):772-8. Epub 2013 May 18.

Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2013.04.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769491PMC
September 2013

Donor lymphocyte infusion: beauty is in the eye of the beholder.

Authors:
Michael R Bishop

Biol Blood Marrow Transplant 2013 Jun 20;19(6):849-50. Epub 2013 Apr 20.

Section of Hematology/Oncology, University of Chicago, Chicago, Illinois 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.04.009DOI Listing
June 2013

Expanded indications for allogeneic stem cell transplantation in patients with myeloid malignancies.

Curr Opin Hematol 2013 Mar;20(2):115-22

Section of Hematology/Oncology, University of Chicago, Chicago, Illinois 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0b013e32835dd84aDOI Listing
March 2013

Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomas.

Biol Blood Marrow Transplant 2012 May 5;18(5):698-707. Epub 2011 Sep 5.

Pediatric Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S108387911100367
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2011.08.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262116PMC
May 2012

Overview of non-Hodgkin's lymphoma.

Dis Mon 2012 Apr;58(4):208-18

Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.disamonth.2012.01.010DOI Listing
April 2012

Monitoring and prevention of relapse after allogeneic hematopoietic cell transplantation for myeloid malignancies.

Biol Blood Marrow Transplant 2012 Jan;18(1 Suppl):S62-73

Department for Stem Cell Transplantation, University of Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2011.10.028DOI Listing
January 2012

Reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma: a concise review.

Clin Lymphoma Myeloma Leuk 2011 Jun 20;11(3):247-52. Epub 2011 Apr 20.

Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2011.03.010DOI Listing
June 2011

The evolving world of tumor lysis syndrome.

Oncology (Williston Park) 2011 Apr;25(4):378, 380

Experimental Transplantation and Immunology Branch, National Cancer Institute, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
April 2011

Minimal residual disease following allogeneic hematopoietic stem cell transplantation.

Biol Blood Marrow Transplant 2011 Jan 1;17(1 Suppl):S94-100. Epub 2010 Nov 1.

University Hospital Hamburg-Eppendorf, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2010.10.031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056549PMC
January 2011

Allogeneic hematopoietic stem cell transplantation: does it have a place in treating Hodgkin lymphoma?

Curr Hematol Malig Rep 2010 Oct;5(4):229-38

Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1203, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11899-010-0065-7
Publisher Site
http://dx.doi.org/10.1007/s11899-010-0065-7DOI Listing
October 2010

Hematopoietic stem cell transplantation. Introduction.

Authors:
Michael R Bishop

Cancer Treat Res 2009 ;144:ix-x

View Article

Download full-text PDF

Source
September 2010

Principles and overview of allogeneic hematopoietic stem cell transplantation.

Cancer Treat Res 2009 ;144:1-21

M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-0-387-78580-6_1DOI Listing
September 2010

Relapse after allogeneic hematopoietic cell therapy.

Biol Blood Marrow Transplant 2010 Jan 24;16(1 Suppl):S138-45. Epub 2009 Oct 24.

Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2009.10.023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637945PMC
January 2010

A human monoclonal antibody drug and target discovery platform for B-cell chronic lymphocytic leukemia based on allogeneic hematopoietic stem cell transplantation and phage display.

Blood 2009 Nov 10;114(20):4494-502. Epub 2009 Aug 10.

Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1203, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2009-05-222786DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2777128PMC
November 2009

Emergencies related to cancer chemotherapy and hematopoietic stem cell transplantation.

Emerg Med Clin North Am 2009 May;27(2):311-31

Medical Oncology Branch, National Cancer Institute, 10 Center Drive, CRC/Room 12N226, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.emc.2009.01.005DOI Listing
May 2009

Association of serum interleukin-7 levels with the development of acute graft-versus-host disease.

J Clin Oncol 2008 Dec 10;26(35):5735-41. Epub 2008 Nov 10.

Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.17.1314DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2645098PMC
December 2008

Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population.

Blood 2008 Sep 3;112(5):2092-100. Epub 2008 Jun 3.

Department of Transfusion Medicine, Warren Grant Magnuson Clinical Center, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2008-03-143677DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518908PMC
September 2008

Bioethical considerations of monoclonal B-cell lymphocytosis: donor transfer after haematopoietic stem cell transplantation.

Br J Haematol 2007 Dec;139(5):824-31

Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2007.06862.xDOI Listing
December 2007

Host T cells affect donor T cell engraftment and graft-versus-host disease after reduced-intensity hematopoietic stem cell transplantation.

Biol Blood Marrow Transplant 2007 Sep 16;13(9):1022-30. Epub 2007 Jul 16.

Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2007.05.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699412PMC
September 2007

Monoclonal antibody therapy.

Front Biosci 2006 May 1;11:1620-35. Epub 2006 May 1.

Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2741/1909DOI Listing
May 2006

Immunotherapy of metastatic breast cancer: phase I trail of reduced-intensity allogeneic hematopoietic stem cell transplantation with Th2/Tc2 T-cell exchange.

Clin Breast Cancer 2006 Apr;7(1):87-9

National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
April 2006

Efficacy of reduced-intensity allogeneic stem cell transplantation in chemotherapy-refractory non-hodgkin lymphoma.

Biol Blood Marrow Transplant 2005 Aug;11(8):593-9

Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892-1203, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S108387910500261
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2005.04.005DOI Listing
August 2005

Unrelated donor marrow transplantation for B-cell chronic lymphocytic leukemia after using myeloablative conditioning: results from the Center for International Blood and Marrow Transplant research.

J Clin Oncol 2005 Aug 25;23(24):5788-94. Epub 2005 Jul 25.

Graft-versus-Host and Autoimmunity Unit, Experimental Transplantation and Immunology Branch, National Cancer Institute, 9000 Rockville Pike, Building 10, Room CRC 3-3330, Bethesda, MD 20892-1907, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.03.962DOI Listing
August 2005

Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.

Am J Hematol 2005 Apr;78(4):265-74

Department of Internal Medicine, Section of Oncology-Hematology, University of Nebraska Medical Center, Omaha, Nebraska, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.20275DOI Listing
April 2005

Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancer.

J Clin Oncol 2004 Oct 16;22(19):3886-92. Epub 2004 Aug 16.

Experimental Transplantation and Immunology Branch, Center for Cancer Research/National Cancer Institute/National Institutes of Health, Building 10, Room 12N226, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2004.01.127DOI Listing
October 2004

Allogeneic hematopoietic stem cell transplantation for metastatic breast cancer.

Authors:
Michael R Bishop

Haematologica 2004 May;89(5):599-605

Experimental Transplantation and Immunology Branch, National Cancer Institute, Building 10, Room 12N226 Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
May 2004

Clinical "cytokine storm" as revealed by monocyte intracellular flow cytometry: correlation of tumor necrosis factor alpha with severe gut graft-versus-host disease.

Clin Gastroenterol Hepatol 2004 Mar;2(3):237-45

Department of Experimental Transplantation and Immunology, National Cancer Institute, Center for Cancer Research, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
March 2004

Allogeneic hematopoietic stem cell transplantation for lymphoma.

Clin Lymphoma 2004 Mar;4(4):238-49

Experimental Transplantation and Immunology Branch Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
March 2004

Adoptive immunotherapy with antigen-specific T cells in myeloma: a model of tumor-specific donor lymphocyte infusion.

Semin Oncol 2004 Feb;31(1):37-46

Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
February 2004

Immunoablative reduced-intensity stem cell transplantation: potential role of donor Th2 and Tc2 cells.

Semin Oncol 2004 Feb;31(1):56-67

National Institutes of Health, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
February 2004

The graft-versus-lymphoma effect: fact, fiction, or opportunity?

Authors:
Michael R Bishop

J Clin Oncol 2003 Oct 8;21(20):3713-5. Epub 2003 Sep 8.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2003.05.984DOI Listing
October 2003

Graft-versus-host disease: emerging concepts in prevention and therapy.

Curr Hematol Rep 2003 Jul;2(4):287-94

Medical Oncology Clinical Research Unit, Experimental Transplant and Immunology Branch, Center for Cancer Research, National Cancer Institute, Building 10, Room 12N226, 10 Center Drive, MSC 1906, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
July 2003

Immunotherapy for breast cancer.

Cancer Chemother Biol Response Modif 2002 ;20:351-69

Tumor Vaccine Group, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
May 2003

Nonmyeloablative allogeneic hematopoietic stem cell transplantation for metastatic breast cancer.

Authors:
Michael R Bishop

Clin Breast Cancer 2003 Apr;4(1):39-45

National Cancer Institute, Medicine Branch, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
April 2003